The decline in Medifast's stock price is directly attributed to the mixed Q1 financial results reported by the company. Such financial announcements typically have a significant impact on stock prices, especially when results do not meet market expectations. The negative reaction suggests that investors may have had higher expectations for the company's financial performance, leading to a sell-off in the short term.